🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in users administering products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the service has removed problematic material and banned related keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at residence.

Within moments of entering one community, a vendor shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, posts display black plastic packages with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram stated it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly serious health risks”.